Reynolds M
Department of Pediatric Surgery, Children's Memorial Hospital, Chicago, Illinois 60614, USA.
World J Surg. 1995 Nov-Dec;19(6):814-6. doi: 10.1007/BF00299776.
In children with hepatoblastoma, cure or a prolonged disease-free interval can only be accomplished with surgical resection of the primary tumor. Less than 50% of children with hepatoblastoma are felt to have resectable tumors at the time of diagnosis. Clinical studies have recently focused on the hypothesis that adjuvant chemotherapy can convert the unresectable tumor to a tumor that can be resected. Short-term outcomes for patients treated with adjuvant chemotherapy and subsequent resection are nearly equal to those patients treated with initial resection followed by chemotherapy. This study is a review of the current literature of the chemotherapeutic conversion of unresectable hepatoblastoma and an update on the long-term follow-up of some of these patients.
在肝母细胞瘤患儿中,只有通过手术切除原发肿瘤才能实现治愈或延长无病生存期。诊断时,不到50%的肝母细胞瘤患儿被认为肿瘤可切除。临床研究最近聚焦于这样一种假说,即辅助化疗可将不可切除的肿瘤转化为可切除的肿瘤。接受辅助化疗并随后进行手术切除的患者的短期预后与那些先进行初次手术切除然后化疗的患者几乎相同。本研究是对不可切除肝母细胞瘤化疗转化的当前文献综述以及其中一些患者长期随访的最新情况。